Biprel

Biprel is a pharmaceutical company based in France and a subsidiary of the Servier Group. The company is primarily focused on the commercialization of cardiovascular medications, most notably the fixed-dose combination of perindopril and indapamide, which is marketed under the brand name Biprel. This therapeutic product is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled by perindopril alone. As a specialized entity within the Servier portfolio, Biprel supports the group's broader mission in cardiovascular health through targeted product management and distribution.